These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 6137390

  • 1. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.
    Goldstein JM, Knobloch LC, Malick JB.
    Eur J Pharmacol; 1983 Jul 15; 91(1):101-5. PubMed ID: 6137390
    [Abstract] [Full Text] [Related]

  • 2. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC, Roach AG, Strachan DA, Virdee NK.
    Br J Pharmacol; 1984 Nov 15; 83(3):713-22. PubMed ID: 6150740
    [Abstract] [Full Text] [Related]

  • 3. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC, Roach AG, Smith CF.
    Br J Pharmacol; 1983 Mar 15; 78(3):489-505. PubMed ID: 6132640
    [Abstract] [Full Text] [Related]

  • 4. Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.
    Freedman JE, Aghajanian GK.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):265-72. PubMed ID: 6150858
    [Abstract] [Full Text] [Related]

  • 5. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
    Gadie B, Lane AC, McCarthy PS, Tulloch IF, Walter DS.
    Br J Pharmacol; 1984 Nov 15; 83(3):707-12. PubMed ID: 6150739
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
    Sanger DJ.
    Psychopharmacology (Berl); 1989 Nov 15; 99(1):117-21. PubMed ID: 2571173
    [Abstract] [Full Text] [Related]

  • 7. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
    Timmermans PB, Qian JQ, Ruffolo RR, van Zwieten PA.
    J Pharmacol Exp Ther; 1984 Mar 15; 228(3):739-48. PubMed ID: 6142941
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors.
    Curet O, de Montigny C.
    Brain Res; 1989 Oct 09; 499(1):18-26. PubMed ID: 2572297
    [Abstract] [Full Text] [Related]

  • 9. Neuropharmacological studies in rodents on the action of RX 781094, a new selective alpha 2-adrenoceptor antagonist.
    Dettmar PW, Lynn AG, Tulloch IF.
    Neuropharmacology; 1983 Jun 09; 22(6):729-37. PubMed ID: 6136932
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D, Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Jun 09; 115(4):689-95. PubMed ID: 7582492
    [Abstract] [Full Text] [Related]

  • 11. Pertussis toxin blocks the effects of alpha 2-agonists and antagonists on locus coeruleus activity in vivo.
    Simson PE, Cierpial MA, Heyneman LE, Weiss JM.
    Neurosci Lett; 1988 Jul 08; 89(3):361-6. PubMed ID: 2901703
    [Abstract] [Full Text] [Related]

  • 12. Imidazolinic radioligands for the identification of hamster adipocyte alpha 2-adrenoceptors.
    Saulnier-Blache JS, Carpéné C, Langin D, Lafontan M.
    Eur J Pharmacol; 1989 Nov 21; 171(2-3):145-57. PubMed ID: 2575998
    [Abstract] [Full Text] [Related]

  • 13. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W, Raulf M, Otto T, Michel MC.
    J Pharmacol Exp Ther; 1995 Jun 21; 273(3):1287-94. PubMed ID: 7791100
    [Abstract] [Full Text] [Related]

  • 14. alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system.
    Berridge TL, Gadie B, Roach AG, Tulloch IF.
    Br J Pharmacol; 1983 Mar 21; 78(3):507-15. PubMed ID: 6132641
    [Abstract] [Full Text] [Related]

  • 15. The alpha 2-adrenoceptor antagonists idazoxan and yohimbine increase rates of DRL responding in rats.
    Sanger DJ.
    Psychopharmacology (Berl); 1988 Mar 21; 95(3):413-7. PubMed ID: 2901129
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity.
    Parfitt KD, Freedman R, Bickford-Wimer PC.
    Brain Res; 1988 Oct 18; 462(2):242-51. PubMed ID: 2847850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation.
    Simson PE, Weiss JM.
    J Neurosci; 1987 Jun 18; 7(6):1732-40. PubMed ID: 2885401
    [Abstract] [Full Text] [Related]

  • 20. Effects of the alpha 2-adrenoceptor antagonists yohimbine and idazoxan on kidney function in intact and diabetes insipidus rats.
    Farjam A, Greven J.
    Urol Int; 1989 Jun 18; 44(5):255-9. PubMed ID: 2572085
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.